Published in Ann N Y Acad Sci on January 01, 1987
Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest (1989) 0.95
Antigenic role of single residues within the main immunogenic region of the nicotinic acetylcholine receptor. Biochem J (1990) 0.82
Protein blotting: principles and applications. Anal Biochem (1983) 4.27
Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein. Cell (1985) 4.02
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature (1994) 3.70
Cytoplasmic heat shock granules are formed from precursor particles and are associated with a specific set of mRNAs. Mol Cell Biol (1989) 3.65
Formation of cytoplasmic heat shock granules in tomato cell cultures and leaves. Mol Cell Biol (1983) 3.19
Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet (1990) 2.93
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain (2005) 2.88
Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to a positively charged membrane filter. Anal Biochem (1982) 2.51
Tolerance to toxic metals by a gene family of phytochelatin synthases from plants and yeast. EMBO J (1999) 2.24
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology (2008) 2.12
Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J Clin Invest (1995) 2.06
All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett (1990) 2.05
Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides. Nat Med (1995) 1.99
The binding site of acetylcholine receptor as visualized in the X-Ray structure of a complex between alpha-bungarotoxin and a mimotope peptide. Neuron (2001) 1.96
Total synthesis of the structural gene for the precursor of a tyrosine suppressor transfer RNA from Escherichia coli. 1. General introduction. J Biol Chem (1976) 1.91
Structure, function, and activation of the erythropoietin receptor. Blood (1993) 1.77
Studies on the regulation and localization of the glyoxylate cycle enzymes in Saccharomyces cerevisiae. Eur J Biochem (1969) 1.76
Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology (2003) 1.60
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J Clin Invest (1988) 1.57
The effect of povidone-iodine solution applied at the conclusion of ophthalmic surgery. Am J Ophthalmol (1995) 1.56
Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol (2000) 1.47
Sleep disorders and melatonin rhythms in elderly people. BMJ (1994) 1.45
Analysis of antibody gene rearrangement, usage, and specificity in chronic focal encephalitis. Neurology (2002) 1.45
Transcriptional regulation of ferritin H and L subunits in adult erythroid and liver cells from the mouse. Unambiguous identification of mouse ferritin subunits and in vitro formation of the ferritin shells. J Biol Chem (1989) 1.44
Binding of alpha-bungarotoxin to isolated alpha subunit of the acetylcholine receptor of Torpedo californica: quantitative analysis with protein blots. Proc Natl Acad Sci U S A (1983) 1.42
Heat shock induced changes of plant cell ultrastructure and autoradiographic localization of heat shock proteins. Eur J Cell Biol (1984) 1.41
Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing. J Immunother (2001) 1.41
Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun (1980) 1.39
ARX mutations in X-linked lissencephaly with abnormal genitalia. Neurology (2003) 1.36
Both megakaryocytopoiesis and erythropoiesis are induced in mice infected with a retrovirus expressing an oncogenic erythropoietin receptor. Blood (1993) 1.33
Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells. Proc Natl Acad Sci U S A (1978) 1.33
Mapping of the alpha-bungarotoxin binding site within the alpha subunit of the acetylcholine receptor. Proc Natl Acad Sci U S A (1986) 1.32
Protein blotting in uniform or gradient electric fields. Anal Biochem (1985) 1.28
Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria. J Med Chem (2000) 1.25
Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Antimicrob Agents Chemother (1992) 1.25
Myasthenia gravis: prolonged treatment with steroids. Neurology (1984) 1.25
Antibodies to synthetic peptides as probes for the binding site on the alpha subunit of the acetylcholine receptor. Proc Natl Acad Sci U S A (1985) 1.25
Closed head trauma and aphasia. J Neurol Neurosurg Psychiatry (1971) 1.23
Biotin binding to avidin. Oligosaccharide side chain not required for ligand association. Biochem J (1987) 1.22
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proc Natl Acad Sci U S A (2001) 1.20
Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor. Curr Biol (2001) 1.19
Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia. Neurology (2005) 1.18
The hemagglutinin envelope protein of canine distemper virus (CDV) confers cell tropism as illustrated by CDV and measles virus complementation analysis. J Virol (1995) 1.18
Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies. Neuromuscul Disord (1999) 1.15
Protein blotting: a manual. Methods Biochem Anal (1988) 1.15
N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity. Peptides (2001) 1.14
Tryptophan residues of cholera toxin and its A and B protomers. Intrinsic fluorescence and solute quenching upon interacting with the ganglioside GM1, oligo-GM1, or dansylated oligo-GM1. J Biol Chem (1981) 1.14
Passive modulation of blood-group antigens. Proc Natl Acad Sci U S A (1979) 1.13
MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope. Eur J Immunol (1999) 1.13
Mutations in the Trp-Ser-X-Trp-Ser motif of the erythropoietin receptor abolish processing, ligand binding, and activation of the receptor. J Biol Chem (1992) 1.12
Binding of alpha-bungarotoxin to proteolytic fragments of the alpha subunit of Torpedo acetylcholine receptor analyzed by protein transfer on positively charged membrane filters. Proc Natl Acad Sci U S A (1984) 1.10
An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J Pharmacol Exp Ther (1991) 1.09
Structure-function studies of cholera toxin and its A and B protomers. Modification of tryptophan residues. J Biol Chem (1981) 1.09
Detection and morphology of thymic remnants after video-assisted thoracoscopic extended thymectomy (VATET) in patients with myasthenia gravis. Int Surg (1996) 1.09
Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype. J Neurol Sci (1995) 1.08
Conformational transitions in CD4 due to complexation with HIV envelope glycoprotein gp120. J Immunol (1997) 1.08
A beta -hairpin structure in a 13-mer peptide that binds alpha -bungarotoxin with high affinity and neutralizes its toxicity. Proc Natl Acad Sci U S A (2001) 1.07
Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies. J Neuropathol Exp Neurol (2000) 1.07
Glucose induced inactivation of malate dehydrogenase in intact yeast cells. Eur J Biochem (1968) 1.07
Calmodulin-stimulated protein kinase activity from rat pancreas. J Cell Biol (1983) 1.06
Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes. Biochim Biophys Acta (1977) 1.06
Decreased tuftsin concentrations in patients who have undergone splenectomy. Br Med J (1977) 1.05
Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor alpha subunit. Proc Natl Acad Sci U S A (1986) 1.05
Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex. FEBS Lett (2001) 1.05
The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide. Biochemistry (2000) 1.05
Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J Pharmacol Exp Ther (1998) 1.04
Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature (1993) 1.03
Structure-function studies of amphiphilic antibacterial peptides. J Med Chem (1993) 1.02
How the mongoose can fight the snake: the binding site of the mongoose acetylcholine receptor. Proc Natl Acad Sci U S A (1992) 1.02
Insulin-like effects of vanadium: basic and clinical implications. J Inorg Biochem (2000) 1.01
Monofunctional substrates of polynucleotide phosphorylase. The monoaddition of 2'(3')-O-isovaleryl-nucleoside diphosphate to an initiator oligonucleotide. Eur J Biochem (1971) 1.01
Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. J Pharmacol Exp Ther (1995) 1.00
The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd. Nucleic Acids Res (2001) 1.00
Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res (1992) 1.00
Fire and insects in northern and boreal forest ecosystems of North America. Annu Rev Entomol (1998) 1.00
Omental infarction: report of three cases and review of the literature. Abdom Imaging (1998) 1.00
Vasoactive intestinal peptide potentiates sexual behavior: inhibition by novel antagonist. Endocrinology (1989) 1.00
The paralimbal approach with deferred conjunctival closure for adjustable strabismus surgery. Ophthalmic Surg Lasers (1998) 0.99
Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci U S A (1999) 0.99
A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses. Proc Natl Acad Sci U S A (1997) 0.99
Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain. Int J Cancer (2000) 0.99
Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables. J Neurol Neurosurg Psychiatry (2009) 0.99
Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. Proc Natl Acad Sci U S A (1996) 0.99
Growth of the internal and external eye in term and preterm infants. Ophthalmology (1995) 0.98
Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome. Proc Natl Acad Sci U S A (1985) 0.98
Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res (2000) 0.98
Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies. Neurology (2011) 0.97
Radioimmunoassay of the phagocytosis-stimulating peptide tuftsin in normal and splenectomized subjects. Eur J Immunol (1977) 0.97
Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney Int (1994) 0.97
Protein blot analysis of virus receptors: identification and characterization of the Sendai virus receptor. Biochim Biophys Acta (1986) 0.97
GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology (2001) 0.97
[Inhibition of dermographism in human skin after topical application of caffeine]. Arch Dermatol Forsch (1972) 0.96